nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—pancreatic cancer	0.17	0.515	CiPCiCtD
Capecitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—pancreatic cancer	0.16	0.485	CiPCiCtD
Capecitabine—TYMP—pancreatic cancer	0.082	0.431	CbGaD
Capecitabine—esophageal cancer—pancreatic cancer	0.0753	0.328	CtDrD
Capecitabine—DPYD—pancreatic cancer	0.0697	0.366	CbGaD
Capecitabine—colon cancer—pancreatic cancer	0.063	0.274	CtDrD
Capecitabine—stomach cancer—pancreatic cancer	0.0512	0.223	CtDrD
Capecitabine—DPYD—Fluorouracil—pancreatic cancer	0.0434	0.245	CbGbCtD
Capecitabine—CDA—Gemcitabine—pancreatic cancer	0.0403	0.227	CbGbCtD
Capecitabine—kidney cancer—pancreatic cancer	0.04	0.174	CtDrD
Capecitabine—TYMS—pancreatic cancer	0.0385	0.203	CbGaD
Capecitabine—TYMP—Fluorouracil—pancreatic cancer	0.0288	0.163	CbGbCtD
Capecitabine—TYMS—Gemcitabine—pancreatic cancer	0.0179	0.101	CbGbCtD
Capecitabine—CES1—Tamoxifen—pancreatic cancer	0.0163	0.0916	CbGbCtD
Capecitabine—TYMS—Fluorouracil—pancreatic cancer	0.0154	0.0865	CbGbCtD
Capecitabine—CES1—Irinotecan—pancreatic cancer	0.0125	0.0703	CbGbCtD
Capecitabine—CYP2C9—Tamoxifen—pancreatic cancer	0.00165	0.00929	CbGbCtD
Capecitabine—CDA—Pyrimidine salvage reactions—TYMP—pancreatic cancer	0.00158	0.0696	CbGpPWpGaD
Capecitabine—DPYD—Pyrimidine catabolism—TYMP—pancreatic cancer	0.00141	0.062	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00125	0.055	CbGpPWpGaD
Capecitabine—CYP2C9—Fluorouracil—pancreatic cancer	0.00122	0.00685	CbGbCtD
Capecitabine—CDA—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00111	0.049	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.000888	0.0392	CbGpPWpGaD
Capecitabine—DPYD—Pyrimidine metabolism—TYMP—pancreatic cancer	0.000808	0.0356	CbGpPWpGaD
Capecitabine—TYMP—Pyrimidine catabolism—DPYD—pancreatic cancer	0.000795	0.0351	CbGpPWpGaD
Capecitabine—CDA—Pyrimidine metabolism—TYMP—pancreatic cancer	0.00072	0.0318	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.000655	0.0289	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000626	0.0276	CbGpPWpGaD
Capecitabine—CDA—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000571	0.0252	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000558	0.0246	CbGpPWpGaD
Capecitabine—TYMP—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000456	0.0201	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.000455	0.0201	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000442	0.0195	CbGpPWpGaD
Capecitabine—DPYD—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000365	0.0161	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000354	0.0156	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000329	0.0145	CbGpPWpGaD
Capecitabine—CDA—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000325	0.0143	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—TYMP—pancreatic cancer	0.000315	0.0139	CbGpPWpGaD
Capecitabine—TYMS—Pyrimidine metabolism—TYMP—pancreatic cancer	0.000294	0.013	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—FGF13—pancreatic cancer	0.000288	0.0127	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000283	0.0125	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—TYMP—pancreatic cancer	0.00028	0.0124	CbGpPWpGaD
Capecitabine—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	0.000266	0.451	CbGdCrCtD
Capecitabine—CES1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000261	0.0115	CbGpPWpGaD
Capecitabine—TYMP—Pyrimidine metabolism—TYMS—pancreatic cancer	0.00026	0.0115	CbGpPWpGaD
Capecitabine—TYMS—Gefitinib—Erlotinib—pancreatic cancer	0.000255	0.432	CbGdCrCtD
Capecitabine—CDA—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000252	0.0111	CbGpPWpGaD
Capecitabine—TYMS—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000233	0.0103	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000228	0.0101	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—DPYD—pancreatic cancer	0.000222	0.00981	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—RBBP8—pancreatic cancer	0.000218	0.00962	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000202	0.00889	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000181	0.00798	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—DPYD—pancreatic cancer	0.000178	0.00784	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—EGF—pancreatic cancer	0.000154	0.00678	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—RBBP8—pancreatic cancer	0.000151	0.00667	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000149	0.00656	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—RB1—pancreatic cancer	0.000144	0.00634	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDH1—pancreatic cancer	0.000143	0.00631	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—TYMS—pancreatic cancer	0.000142	0.00627	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—TYMS—pancreatic cancer	0.000127	0.00559	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDKN2A—pancreatic cancer	0.000126	0.00557	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—TYMP—pancreatic cancer	0.000115	0.00506	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CXCL8—pancreatic cancer	0.000115	0.00505	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CCND1—pancreatic cancer	0.000107	0.00471	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—TYMS—pancreatic cancer	0.000101	0.00447	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—pancreatic cancer	9.38e-05	0.00414	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—VEGFA—pancreatic cancer	9.3e-05	0.0041	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—DPYD—pancreatic cancer	9.09e-05	0.00401	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	8.82e-05	0.00389	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MYC—pancreatic cancer	8.56e-05	0.00378	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—EGFR—pancreatic cancer	8.37e-05	0.00369	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—pancreatic cancer	8.36e-05	0.00369	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—NFE2L2—pancreatic cancer	8.07e-05	0.00356	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—TYMS—pancreatic cancer	7.87e-05	0.00347	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFA—pancreatic cancer	7.7e-05	0.00339	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC2A2—pancreatic cancer	7.53e-05	0.00332	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—TP53—pancreatic cancer	7.03e-05	0.0031	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	6.99e-05	0.00308	CbGpPWpGaD
Capecitabine—TYMS—Azacitidine—Gemcitabine—pancreatic cancer	6.88e-05	0.117	CbGdCrCtD
Capecitabine—TYMP—Bladder Cancer—HRAS—pancreatic cancer	6.72e-05	0.00297	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—pancreatic cancer	6.68e-05	0.00295	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—PLAU—pancreatic cancer	6.5e-05	0.00287	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	6.41e-05	0.00283	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—SYCP1—pancreatic cancer	5.92e-05	0.00261	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—HSPA1A—pancreatic cancer	5.79e-05	0.00255	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—RB1—pancreatic cancer	5.34e-05	0.00235	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—pancreatic cancer	4.93e-05	0.00217	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—pancreatic cancer	4.69e-05	0.00207	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	4.51e-05	0.00199	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—PLAU—pancreatic cancer	4.51e-05	0.00199	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—AHR—pancreatic cancer	4.45e-05	0.00196	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	4.05e-05	0.00179	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	4e-05	0.00176	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PRSS1—pancreatic cancer	3.77e-05	0.00166	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—RB1—pancreatic cancer	3.7e-05	0.00163	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	3.5e-05	0.00154	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	3.44e-05	0.00152	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—pancreatic cancer	3.42e-05	0.00151	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PRSS1—pancreatic cancer	3.36e-05	0.00148	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—EZH2—pancreatic cancer	3.36e-05	0.00148	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ARG2—pancreatic cancer	3.27e-05	0.00144	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—pancreatic cancer	3.26e-05	0.00144	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	3.22e-05	0.00142	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—pancreatic cancer	3.18e-05	0.0014	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RBBP8—pancreatic cancer	3.03e-05	0.00134	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.94e-05	0.0013	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ARG2—pancreatic cancer	2.91e-05	0.00129	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TYMP—pancreatic cancer	2.86e-05	0.00126	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—RB1—pancreatic cancer	2.69e-05	0.00119	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PRSS1—pancreatic cancer	2.69e-05	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	2.66e-05	0.00117	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	2.64e-05	0.00116	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.58e-05	0.00114	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TYMP—pancreatic cancer	2.55e-05	0.00112	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	2.39e-05	0.00105	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PPP2R5B—pancreatic cancer	2.36e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	2.35e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ARG2—pancreatic cancer	2.33e-05	0.00103	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GLP1R—pancreatic cancer	2.3e-05	0.00102	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—RB1—pancreatic cancer	2.26e-05	0.000999	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—pancreatic cancer	2.21e-05	0.000973	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC2A2—pancreatic cancer	2.15e-05	0.000949	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—FOXM1—pancreatic cancer	2.1e-05	0.000927	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	2.06e-05	0.000907	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GLP1R—pancreatic cancer	2.05e-05	0.000906	CbGpPWpGaD
Capecitabine—CDA—Metabolism—DPYD—pancreatic cancer	2.02e-05	0.000891	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	1.99e-05	0.000878	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.92e-05	0.000846	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	1.92e-05	0.000846	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC2A2—pancreatic cancer	1.92e-05	0.000846	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.84e-05	0.00081	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB1—pancreatic cancer	1.82e-05	0.000804	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PPARG—pancreatic cancer	1.72e-05	0.000759	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	1.68e-05	0.000742	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CD44—pancreatic cancer	1.67e-05	0.000735	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GLP1R—pancreatic cancer	1.64e-05	0.000724	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—DPYD—pancreatic cancer	1.61e-05	0.000712	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—pancreatic cancer	1.6e-05	0.000706	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GCG—pancreatic cancer	1.6e-05	0.000704	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	1.57e-05	0.000695	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC2A2—pancreatic cancer	1.53e-05	0.000676	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—STK11—pancreatic cancer	1.5e-05	0.000662	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CD44—pancreatic cancer	1.48e-05	0.000655	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GCG—pancreatic cancer	1.42e-05	0.000628	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.41e-05	0.000622	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PRSS1—pancreatic cancer	1.37e-05	0.000606	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—pancreatic cancer	1.35e-05	0.000595	CbGpPWpGaD
Capecitabine—CDA—Metabolism—STK11—pancreatic cancer	1.34e-05	0.00059	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.31e-05	0.000578	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TYMS—pancreatic cancer	1.29e-05	0.00057	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.27e-05	0.000562	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.26e-05	0.000557	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.23e-05	0.000543	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ARG2—pancreatic cancer	1.19e-05	0.000526	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	1.19e-05	0.000524	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CD44—pancreatic cancer	1.19e-05	0.000523	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—pancreatic cancer	1.18e-05	0.000521	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BRCA2—pancreatic cancer	1.15e-05	0.000508	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000508	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.14e-05	0.000503	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GCG—pancreatic cancer	1.14e-05	0.000502	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.11e-05	0.00049	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—STK11—pancreatic cancer	1.07e-05	0.000472	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOE—pancreatic cancer	1.05e-05	0.000463	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—TYMP—pancreatic cancer	1.04e-05	0.00046	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.02e-05	0.000451	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.02e-05	0.00045	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1e-05	0.000441	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—pancreatic cancer	9.54e-06	0.000421	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.52e-06	0.00042	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—pancreatic cancer	9.48e-06	0.000418	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.44e-06	0.000417	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOE—pancreatic cancer	9.36e-06	0.000413	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TYMS—pancreatic cancer	9.2e-06	0.000406	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARG—pancreatic cancer	9.15e-06	0.000404	CbGpPWpGaD
Capecitabine—Hypersensitivity—Fluorouracil—pancreatic cancer	8.82e-06	0.000177	CcSEcCtD
Capecitabine—Dry mouth—Docetaxel—pancreatic cancer	8.82e-06	0.000177	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	8.81e-06	0.000177	CcSEcCtD
Capecitabine—Asthenia—Gemcitabine—pancreatic cancer	8.74e-06	0.000175	CcSEcCtD
Capecitabine—Haematuria—Epirubicin—pancreatic cancer	8.71e-06	0.000175	CcSEcCtD
Capecitabine—Confusional state—Docetaxel—pancreatic cancer	8.71e-06	0.000175	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.68e-06	0.000383	CbGpPWpGaD
Capecitabine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.66e-06	0.000174	CcSEcCtD
Capecitabine—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.64e-06	0.000173	CcSEcCtD
Capecitabine—Oedema—Docetaxel—pancreatic cancer	8.64e-06	0.000173	CcSEcCtD
Capecitabine—Weight increased—Doxorubicin—pancreatic cancer	8.63e-06	0.000173	CcSEcCtD
Capecitabine—Epistaxis—Epirubicin—pancreatic cancer	8.62e-06	0.000173	CcSEcCtD
Capecitabine—Pruritus—Gemcitabine—pancreatic cancer	8.62e-06	0.000173	CcSEcCtD
Capecitabine—Infection—Docetaxel—pancreatic cancer	8.58e-06	0.000172	CcSEcCtD
Capecitabine—Weight decreased—Doxorubicin—pancreatic cancer	8.58e-06	0.000172	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—pancreatic cancer	8.55e-06	0.000172	CcSEcCtD
Capecitabine—Diarrhoea—Irinotecan—pancreatic cancer	8.55e-06	0.000172	CcSEcCtD
Capecitabine—Agranulocytosis—Epirubicin—pancreatic cancer	8.53e-06	0.000171	CcSEcCtD
Capecitabine—Pneumonia—Doxorubicin—pancreatic cancer	8.51e-06	0.000171	CcSEcCtD
Capecitabine—Shock—Docetaxel—pancreatic cancer	8.5e-06	0.000171	CcSEcCtD
Capecitabine—Nervous system disorder—Docetaxel—pancreatic cancer	8.47e-06	0.00017	CcSEcCtD
Capecitabine—Pruritus—Fluorouracil—pancreatic cancer	8.47e-06	0.00017	CcSEcCtD
Capecitabine—Thrombocytopenia—Docetaxel—pancreatic cancer	8.46e-06	0.00017	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—pancreatic cancer	8.46e-06	0.00017	CcSEcCtD
Capecitabine—Infestation—Doxorubicin—pancreatic cancer	8.46e-06	0.00017	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CG—pancreatic cancer	8.45e-06	0.000373	CbGpPWpGaD
Capecitabine—Tachycardia—Docetaxel—pancreatic cancer	8.43e-06	0.000169	CcSEcCtD
Capecitabine—TYMS—Metabolism—GLP1R—pancreatic cancer	8.4e-06	0.00037	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.39e-06	0.00037	CbGpPWpGaD
Capecitabine—Skin disorder—Docetaxel—pancreatic cancer	8.39e-06	0.000168	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.38e-06	0.000168	CcSEcCtD
Capecitabine—Bradycardia—Epirubicin—pancreatic cancer	8.35e-06	0.000168	CcSEcCtD
Capecitabine—Diarrhoea—Gemcitabine—pancreatic cancer	8.33e-06	0.000167	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CD—pancreatic cancer	8.33e-06	0.000368	CbGpPWpGaD
Capecitabine—Renal failure—Doxorubicin—pancreatic cancer	8.31e-06	0.000167	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—RB1—pancreatic cancer	8.31e-06	0.000366	CbGpPWpGaD
Capecitabine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.29e-06	0.000166	CcSEcCtD
Capecitabine—Dizziness—Irinotecan—pancreatic cancer	8.27e-06	0.000166	CcSEcCtD
Capecitabine—TYMS—Metabolism—DPYD—pancreatic cancer	8.26e-06	0.000364	CbGpPWpGaD
Capecitabine—Haemoglobin—Epirubicin—pancreatic cancer	8.25e-06	0.000165	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—pancreatic cancer	8.24e-06	0.000165	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—pancreatic cancer	8.24e-06	0.000165	CcSEcCtD
Capecitabine—Anorexia—Docetaxel—pancreatic cancer	8.24e-06	0.000165	CcSEcCtD
Capecitabine—Rhinitis—Epirubicin—pancreatic cancer	8.22e-06	0.000165	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—pancreatic cancer	8.22e-06	0.000165	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—pancreatic cancer	8.22e-06	0.000165	CcSEcCtD
Capecitabine—Hepatitis—Epirubicin—pancreatic cancer	8.2e-06	0.000165	CcSEcCtD
Capecitabine—Haemorrhage—Epirubicin—pancreatic cancer	8.2e-06	0.000165	CcSEcCtD
Capecitabine—Diarrhoea—Fluorouracil—pancreatic cancer	8.19e-06	0.000164	CcSEcCtD
Capecitabine—Hypoaesthesia—Epirubicin—pancreatic cancer	8.16e-06	0.000164	CcSEcCtD
Capecitabine—CDA—Metabolism—PPARG—pancreatic cancer	8.15e-06	0.00036	CbGpPWpGaD
Capecitabine—Pharyngitis—Epirubicin—pancreatic cancer	8.14e-06	0.000163	CcSEcCtD
Capecitabine—Urinary tract disorder—Epirubicin—pancreatic cancer	8.1e-06	0.000163	CcSEcCtD
Capecitabine—Oedema peripheral—Epirubicin—pancreatic cancer	8.08e-06	0.000162	CcSEcCtD
Capecitabine—Hypotension—Docetaxel—pancreatic cancer	8.07e-06	0.000162	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—pancreatic cancer	8.06e-06	0.000162	CcSEcCtD
Capecitabine—Connective tissue disorder—Epirubicin—pancreatic cancer	8.06e-06	0.000162	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—pancreatic cancer	8.06e-06	0.000356	CbGpPWpGaD
Capecitabine—Urethral disorder—Epirubicin—pancreatic cancer	8.04e-06	0.000161	CcSEcCtD
Capecitabine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	8e-06	0.00016	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—pancreatic cancer	7.98e-06	0.00016	CcSEcCtD
Capecitabine—Vomiting—Irinotecan—pancreatic cancer	7.95e-06	0.000159	CcSEcCtD
Capecitabine—Dizziness—Fluorouracil—pancreatic cancer	7.92e-06	0.000159	CcSEcCtD
Capecitabine—Visual impairment—Epirubicin—pancreatic cancer	7.91e-06	0.000159	CcSEcCtD
Capecitabine—Agranulocytosis—Doxorubicin—pancreatic cancer	7.89e-06	0.000158	CcSEcCtD
Capecitabine—Rash—Irinotecan—pancreatic cancer	7.88e-06	0.000158	CcSEcCtD
Capecitabine—Dermatitis—Irinotecan—pancreatic cancer	7.87e-06	0.000158	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.87e-06	0.000158	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC2A2—pancreatic cancer	7.84e-06	0.000346	CbGpPWpGaD
Capecitabine—Headache—Irinotecan—pancreatic cancer	7.83e-06	0.000157	CcSEcCtD
Capecitabine—Insomnia—Docetaxel—pancreatic cancer	7.82e-06	0.000157	CcSEcCtD
Capecitabine—Paraesthesia—Docetaxel—pancreatic cancer	7.76e-06	0.000156	CcSEcCtD
Capecitabine—Erythema multiforme—Epirubicin—pancreatic cancer	7.76e-06	0.000156	CcSEcCtD
Capecitabine—Vomiting—Gemcitabine—pancreatic cancer	7.74e-06	0.000155	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—pancreatic cancer	7.73e-06	0.000155	CcSEcCtD
Capecitabine—Dyspnoea—Docetaxel—pancreatic cancer	7.7e-06	0.000155	CcSEcCtD
Capecitabine—Rash—Gemcitabine—pancreatic cancer	7.68e-06	0.000154	CcSEcCtD
Capecitabine—Dermatitis—Gemcitabine—pancreatic cancer	7.67e-06	0.000154	CcSEcCtD
Capecitabine—Eye disorder—Epirubicin—pancreatic cancer	7.67e-06	0.000154	CcSEcCtD
Capecitabine—Tinnitus—Epirubicin—pancreatic cancer	7.65e-06	0.000153	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—pancreatic cancer	7.63e-06	0.000153	CcSEcCtD
Capecitabine—Headache—Gemcitabine—pancreatic cancer	7.63e-06	0.000153	CcSEcCtD
Capecitabine—Cardiac disorder—Epirubicin—pancreatic cancer	7.61e-06	0.000153	CcSEcCtD
Capecitabine—Flushing—Epirubicin—pancreatic cancer	7.61e-06	0.000153	CcSEcCtD
Capecitabine—Vomiting—Fluorouracil—pancreatic cancer	7.61e-06	0.000153	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—pancreatic cancer	7.61e-06	0.000153	CcSEcCtD
Capecitabine—Dyspepsia—Docetaxel—pancreatic cancer	7.61e-06	0.000153	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—pancreatic cancer	7.59e-06	0.000152	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—pancreatic cancer	7.59e-06	0.000152	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.55e-06	0.000152	CcSEcCtD
Capecitabine—Rash—Fluorouracil—pancreatic cancer	7.55e-06	0.000151	CcSEcCtD
Capecitabine—Dermatitis—Fluorouracil—pancreatic cancer	7.54e-06	0.000151	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—pancreatic cancer	7.53e-06	0.000151	CcSEcCtD
Capecitabine—Decreased appetite—Docetaxel—pancreatic cancer	7.51e-06	0.000151	CcSEcCtD
Capecitabine—Headache—Fluorouracil—pancreatic cancer	7.5e-06	0.00015	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.5e-06	0.00015	CcSEcCtD
Capecitabine—TYMP—Metabolism—APOE—pancreatic cancer	7.48e-06	0.00033	CbGpPWpGaD
Capecitabine—Oedema peripheral—Doxorubicin—pancreatic cancer	7.48e-06	0.00015	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.46e-06	0.00015	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.46e-06	0.00015	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—pancreatic cancer	7.45e-06	0.000149	CcSEcCtD
Capecitabine—Angiopathy—Epirubicin—pancreatic cancer	7.44e-06	0.000149	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—pancreatic cancer	7.44e-06	0.000149	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—RB1—pancreatic cancer	7.43e-06	0.000328	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—pancreatic cancer	7.43e-06	0.000328	CbGpPWpGaD
Capecitabine—Nausea—Irinotecan—pancreatic cancer	7.43e-06	0.000149	CcSEcCtD
Capecitabine—Immune system disorder—Epirubicin—pancreatic cancer	7.41e-06	0.000149	CcSEcCtD
Capecitabine—Mediastinal disorder—Epirubicin—pancreatic cancer	7.39e-06	0.000148	CcSEcCtD
Capecitabine—Pain—Docetaxel—pancreatic cancer	7.39e-06	0.000148	CcSEcCtD
Capecitabine—Constipation—Docetaxel—pancreatic cancer	7.39e-06	0.000148	CcSEcCtD
Capecitabine—Chills—Epirubicin—pancreatic cancer	7.36e-06	0.000148	CcSEcCtD
Capecitabine—Arrhythmia—Epirubicin—pancreatic cancer	7.33e-06	0.000147	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—pancreatic cancer	7.32e-06	0.000147	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	7.3e-06	0.000322	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CB—pancreatic cancer	7.26e-06	0.00032	CbGpPWpGaD
Capecitabine—Alopecia—Epirubicin—pancreatic cancer	7.25e-06	0.000145	CcSEcCtD
Capecitabine—Nausea—Gemcitabine—pancreatic cancer	7.23e-06	0.000145	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTGS2—pancreatic cancer	7.2e-06	0.000317	CbGpPWpGaD
Capecitabine—Mental disorder—Epirubicin—pancreatic cancer	7.19e-06	0.000144	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—pancreatic cancer	7.18e-06	0.000144	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—pancreatic cancer	7.14e-06	0.000143	CcSEcCtD
Capecitabine—Erythema—Epirubicin—pancreatic cancer	7.14e-06	0.000143	CcSEcCtD
Capecitabine—Feeling abnormal—Docetaxel—pancreatic cancer	7.12e-06	0.000143	CcSEcCtD
Capecitabine—Nausea—Fluorouracil—pancreatic cancer	7.11e-06	0.000143	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—pancreatic cancer	7.09e-06	0.000142	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.09e-06	0.000313	CbGpPWpGaD
Capecitabine—Tinnitus—Doxorubicin—pancreatic cancer	7.08e-06	0.000142	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.07e-06	0.000142	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—pancreatic cancer	7.05e-06	0.000141	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—pancreatic cancer	7.05e-06	0.000141	CcSEcCtD
Capecitabine—Flatulence—Epirubicin—pancreatic cancer	7.04e-06	0.000141	CcSEcCtD
Capecitabine—Dysgeusia—Epirubicin—pancreatic cancer	6.99e-06	0.00014	CcSEcCtD
Capecitabine—Back pain—Epirubicin—pancreatic cancer	6.91e-06	0.000139	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—pancreatic cancer	6.89e-06	0.000138	CcSEcCtD
Capecitabine—Muscle spasms—Epirubicin—pancreatic cancer	6.87e-06	0.000138	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—pancreatic cancer	6.86e-06	0.000138	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.84e-06	0.000137	CcSEcCtD
Capecitabine—Abdominal pain—Docetaxel—pancreatic cancer	6.83e-06	0.000137	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—pancreatic cancer	6.83e-06	0.000137	CcSEcCtD
Capecitabine—Chills—Doxorubicin—pancreatic cancer	6.81e-06	0.000137	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—pancreatic cancer	6.78e-06	0.000136	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CG—pancreatic cancer	6.75e-06	0.000298	CbGpPWpGaD
Capecitabine—Vision blurred—Epirubicin—pancreatic cancer	6.73e-06	0.000135	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—pancreatic cancer	6.71e-06	0.000135	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—pancreatic cancer	6.65e-06	0.000133	CcSEcCtD
Capecitabine—Ill-defined disorder—Epirubicin—pancreatic cancer	6.63e-06	0.000133	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—pancreatic cancer	6.61e-06	0.000133	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—pancreatic cancer	6.61e-06	0.000133	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—pancreatic cancer	6.6e-06	0.000132	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN2A—pancreatic cancer	6.53e-06	0.000288	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—pancreatic cancer	6.52e-06	0.000288	CbGpPWpGaD
Capecitabine—Flatulence—Doxorubicin—pancreatic cancer	6.51e-06	0.000131	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CB—pancreatic cancer	6.47e-06	0.000286	CbGpPWpGaD
Capecitabine—Dysgeusia—Doxorubicin—pancreatic cancer	6.47e-06	0.00013	CcSEcCtD
Capecitabine—Malaise—Epirubicin—pancreatic cancer	6.44e-06	0.000129	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—pancreatic cancer	6.42e-06	0.000129	CcSEcCtD
Capecitabine—CDA—Metabolism—PTGS2—pancreatic cancer	6.41e-06	0.000283	CbGpPWpGaD
Capecitabine—Syncope—Epirubicin—pancreatic cancer	6.4e-06	0.000129	CcSEcCtD
Capecitabine—Leukopenia—Epirubicin—pancreatic cancer	6.39e-06	0.000128	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—pancreatic cancer	6.39e-06	0.000128	CcSEcCtD
Capecitabine—Hypersensitivity—Docetaxel—pancreatic cancer	6.37e-06	0.000128	CcSEcCtD
Capecitabine—Muscle spasms—Doxorubicin—pancreatic cancer	6.35e-06	0.000127	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—pancreatic cancer	6.31e-06	0.000127	CcSEcCtD
Capecitabine—Loss of consciousness—Epirubicin—pancreatic cancer	6.28e-06	0.000126	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTEN—pancreatic cancer	6.28e-06	0.000277	CbGpPWpGaD
Capecitabine—Cough—Epirubicin—pancreatic cancer	6.23e-06	0.000125	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—pancreatic cancer	6.23e-06	0.000125	CcSEcCtD
Capecitabine—Asthenia—Docetaxel—pancreatic cancer	6.2e-06	0.000124	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—pancreatic cancer	6.17e-06	0.000272	CbGpPWpGaD
Capecitabine—Hypertension—Epirubicin—pancreatic cancer	6.17e-06	0.000124	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.13e-06	0.000123	CcSEcCtD
Capecitabine—Pruritus—Docetaxel—pancreatic cancer	6.11e-06	0.000123	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—pancreatic cancer	6.11e-06	0.000123	CcSEcCtD
Capecitabine—Myalgia—Epirubicin—pancreatic cancer	6.08e-06	0.000122	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—pancreatic cancer	6.08e-06	0.000122	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—pancreatic cancer	6.08e-06	0.000122	CcSEcCtD
Capecitabine—TYMS—Metabolism—CD44—pancreatic cancer	6.07e-06	0.000268	CbGpPWpGaD
Capecitabine—Anxiety—Epirubicin—pancreatic cancer	6.06e-06	0.000122	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.04e-06	0.000121	CcSEcCtD
Capecitabine—Discomfort—Epirubicin—pancreatic cancer	6.01e-06	0.000121	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—pancreatic cancer	5.96e-06	0.00012	CcSEcCtD
Capecitabine—Dry mouth—Epirubicin—pancreatic cancer	5.95e-06	0.000119	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—pancreatic cancer	5.94e-06	0.000119	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CD—pancreatic cancer	5.94e-06	0.000262	CbGpPWpGaD
Capecitabine—Syncope—Doxorubicin—pancreatic cancer	5.93e-06	0.000119	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—pancreatic cancer	5.92e-06	0.000119	CcSEcCtD
Capecitabine—Diarrhoea—Docetaxel—pancreatic cancer	5.91e-06	0.000119	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—pancreatic cancer	5.88e-06	0.000118	CcSEcCtD
Capecitabine—Palpitations—Doxorubicin—pancreatic cancer	5.84e-06	0.000117	CcSEcCtD
Capecitabine—Oedema—Epirubicin—pancreatic cancer	5.83e-06	0.000117	CcSEcCtD
Capecitabine—TYMS—Metabolism—GCG—pancreatic cancer	5.82e-06	0.000257	CbGpPWpGaD
Capecitabine—Loss of consciousness—Doxorubicin—pancreatic cancer	5.81e-06	0.000117	CcSEcCtD
Capecitabine—Infection—Epirubicin—pancreatic cancer	5.79e-06	0.000116	CcSEcCtD
Capecitabine—Cough—Doxorubicin—pancreatic cancer	5.77e-06	0.000116	CcSEcCtD
Capecitabine—Shock—Epirubicin—pancreatic cancer	5.73e-06	0.000115	CcSEcCtD
Capecitabine—Nervous system disorder—Epirubicin—pancreatic cancer	5.72e-06	0.000115	CcSEcCtD
Capecitabine—Dizziness—Docetaxel—pancreatic cancer	5.71e-06	0.000115	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.71e-06	0.000115	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—pancreatic cancer	5.71e-06	0.000114	CcSEcCtD
Capecitabine—Tachycardia—Epirubicin—pancreatic cancer	5.69e-06	0.000114	CcSEcCtD
Capecitabine—Skin disorder—Epirubicin—pancreatic cancer	5.66e-06	0.000114	CcSEcCtD
Capecitabine—Hyperhidrosis—Epirubicin—pancreatic cancer	5.63e-06	0.000113	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—pancreatic cancer	5.63e-06	0.000113	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—pancreatic cancer	5.63e-06	0.000113	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—pancreatic cancer	5.63e-06	0.000113	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—pancreatic cancer	5.61e-06	0.000112	CcSEcCtD
Capecitabine—CDA—Metabolism—PTEN—pancreatic cancer	5.59e-06	0.000247	CbGpPWpGaD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.59e-06	0.000112	CcSEcCtD
Capecitabine—Discomfort—Doxorubicin—pancreatic cancer	5.56e-06	0.000112	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—pancreatic cancer	5.56e-06	0.000111	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CCND1—pancreatic cancer	5.52e-06	0.000243	CbGpPWpGaD
Capecitabine—Dry mouth—Doxorubicin—pancreatic cancer	5.5e-06	0.00011	CcSEcCtD
Capecitabine—Vomiting—Docetaxel—pancreatic cancer	5.49e-06	0.00011	CcSEcCtD
Capecitabine—TYMS—Metabolism—STK11—pancreatic cancer	5.47e-06	0.000241	CbGpPWpGaD
Capecitabine—Rash—Docetaxel—pancreatic cancer	5.45e-06	0.000109	CcSEcCtD
Capecitabine—Hypotension—Epirubicin—pancreatic cancer	5.45e-06	0.000109	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—pancreatic cancer	5.44e-06	0.000109	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—pancreatic cancer	5.44e-06	0.000109	CcSEcCtD
Capecitabine—Headache—Docetaxel—pancreatic cancer	5.41e-06	0.000109	CcSEcCtD
Capecitabine—Oedema—Doxorubicin—pancreatic cancer	5.39e-06	0.000108	CcSEcCtD
Capecitabine—Infection—Doxorubicin—pancreatic cancer	5.36e-06	0.000108	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.31e-06	0.000107	CcSEcCtD
Capecitabine—Shock—Doxorubicin—pancreatic cancer	5.31e-06	0.000106	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—pancreatic cancer	5.29e-06	0.000106	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.28e-06	0.000106	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—pancreatic cancer	5.27e-06	0.000106	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—pancreatic cancer	5.26e-06	0.000106	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—pancreatic cancer	5.24e-06	0.000105	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—pancreatic cancer	5.23e-06	0.000105	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.21e-06	0.000105	CcSEcCtD
Capecitabine—Dyspnoea—Epirubicin—pancreatic cancer	5.2e-06	0.000104	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CB—pancreatic cancer	5.17e-06	0.000228	CbGpPWpGaD
Capecitabine—Anorexia—Doxorubicin—pancreatic cancer	5.14e-06	0.000103	CcSEcCtD
Capecitabine—Nausea—Docetaxel—pancreatic cancer	5.13e-06	0.000103	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—pancreatic cancer	5.13e-06	0.000103	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTGS2—pancreatic cancer	5.13e-06	0.000226	CbGpPWpGaD
Capecitabine—Decreased appetite—Epirubicin—pancreatic cancer	5.07e-06	0.000102	CcSEcCtD
Capecitabine—Hypotension—Doxorubicin—pancreatic cancer	5.04e-06	0.000101	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.03e-06	0.000101	CcSEcCtD
Capecitabine—Fatigue—Epirubicin—pancreatic cancer	5.03e-06	0.000101	CcSEcCtD
Capecitabine—Pain—Epirubicin—pancreatic cancer	4.98e-06	0.0001	CcSEcCtD
Capecitabine—Constipation—Epirubicin—pancreatic cancer	4.98e-06	0.0001	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.95e-06	0.000218	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.91e-06	9.86e-05	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—pancreatic cancer	4.88e-06	9.79e-05	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—pancreatic cancer	4.84e-06	9.72e-05	CcSEcCtD
Capecitabine—Dyspnoea—Doxorubicin—pancreatic cancer	4.81e-06	9.65e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—pancreatic cancer	4.8e-06	9.64e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.77e-06	9.56e-05	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—pancreatic cancer	4.75e-06	9.53e-05	CcSEcCtD
Capecitabine—Decreased appetite—Doxorubicin—pancreatic cancer	4.69e-06	9.41e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.66e-06	9.34e-05	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—pancreatic cancer	4.65e-06	9.33e-05	CcSEcCtD
Capecitabine—Urticaria—Epirubicin—pancreatic cancer	4.63e-06	9.29e-05	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—pancreatic cancer	4.61e-06	9.25e-05	CcSEcCtD
Capecitabine—Pain—Doxorubicin—pancreatic cancer	4.61e-06	9.25e-05	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—pancreatic cancer	4.61e-06	9.24e-05	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—pancreatic cancer	4.61e-06	9.24e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTEN—pancreatic cancer	4.47e-06	0.000197	CbGpPWpGaD
Capecitabine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.44e-06	8.92e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CA—pancreatic cancer	4.43e-06	0.000195	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—pancreatic cancer	4.42e-06	0.000195	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.41e-06	8.85e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Epirubicin—pancreatic cancer	4.29e-06	8.62e-05	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—pancreatic cancer	4.28e-06	8.6e-05	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—pancreatic cancer	4.26e-06	8.55e-05	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—pancreatic cancer	4.26e-06	8.55e-05	CcSEcCtD
Capecitabine—Asthenia—Epirubicin—pancreatic cancer	4.18e-06	8.39e-05	CcSEcCtD
Capecitabine—Pruritus—Epirubicin—pancreatic cancer	4.12e-06	8.27e-05	CcSEcCtD
Capecitabine—Diarrhoea—Epirubicin—pancreatic cancer	3.99e-06	8e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.97e-06	7.97e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—PRSS1—pancreatic cancer	3.96e-06	0.000175	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—pancreatic cancer	3.95e-06	0.000174	CbGpPWpGaD
Capecitabine—Asthenia—Doxorubicin—pancreatic cancer	3.87e-06	7.76e-05	CcSEcCtD
Capecitabine—Dizziness—Epirubicin—pancreatic cancer	3.85e-06	7.73e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—APOE—pancreatic cancer	3.83e-06	0.000169	CbGpPWpGaD
Capecitabine—Pruritus—Doxorubicin—pancreatic cancer	3.82e-06	7.66e-05	CcSEcCtD
Capecitabine—Vomiting—Epirubicin—pancreatic cancer	3.71e-06	7.44e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—pancreatic cancer	3.69e-06	7.4e-05	CcSEcCtD
Capecitabine—Rash—Epirubicin—pancreatic cancer	3.68e-06	7.37e-05	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—pancreatic cancer	3.67e-06	7.37e-05	CcSEcCtD
Capecitabine—Headache—Epirubicin—pancreatic cancer	3.65e-06	7.33e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TP53—pancreatic cancer	3.63e-06	0.00016	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—pancreatic cancer	3.62e-06	0.00016	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—pancreatic cancer	3.57e-06	7.16e-05	CcSEcCtD
Capecitabine—Nausea—Epirubicin—pancreatic cancer	3.46e-06	6.95e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PIK3CG—pancreatic cancer	3.45e-06	0.000152	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ARG2—pancreatic cancer	3.43e-06	0.000152	CbGpPWpGaD
Capecitabine—Vomiting—Doxorubicin—pancreatic cancer	3.43e-06	6.88e-05	CcSEcCtD
Capecitabine—Rash—Doxorubicin—pancreatic cancer	3.4e-06	6.82e-05	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—pancreatic cancer	3.4e-06	6.82e-05	CcSEcCtD
Capecitabine—Headache—Doxorubicin—pancreatic cancer	3.38e-06	6.78e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PPARG—pancreatic cancer	3.33e-06	0.000147	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—pancreatic cancer	3.22e-06	0.000142	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—pancreatic cancer	3.2e-06	6.43e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CA—pancreatic cancer	3.15e-06	0.000139	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—pancreatic cancer	3.04e-06	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMP—pancreatic cancer	3e-06	0.000132	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	0.000117	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—pancreatic cancer	2.62e-06	0.000116	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—pancreatic cancer	2.58e-06	0.000114	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.48e-06	0.000109	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	2.42e-06	0.000107	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—DPYD—pancreatic cancer	2.38e-06	0.000105	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—pancreatic cancer	2.29e-06	0.000101	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	2.26e-06	9.97e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.24e-06	9.86e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.16e-06	9.52e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.97e-06	8.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CD44—pancreatic cancer	1.75e-06	7.72e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.71e-06	7.56e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.7e-06	7.49e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCG—pancreatic cancer	1.68e-06	7.4e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—pancreatic cancer	1.61e-06	7.12e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—STK11—pancreatic cancer	1.58e-06	6.96e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.48e-06	6.53e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.36e-06	5.99e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—pancreatic cancer	1.32e-06	5.82e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOE—pancreatic cancer	1.1e-06	4.87e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.04e-06	4.61e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	9.96e-07	4.39e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—pancreatic cancer	9.61e-07	4.24e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	8.75e-07	3.86e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	7.63e-07	3.37e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	7.56e-07	3.34e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—pancreatic cancer	6.59e-07	2.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	4.65e-07	2.05e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—pancreatic cancer	3.8e-07	1.68e-05	CbGpPWpGaD
